Vaccine for lung cancer soon begins at Papageorgiou Hospital as part of a clinical trial of personalized treatment.

Research has begun in the last four months, in succession in over 20 countries, including in Greece and will include more than 600 patients.

The vaccine will be administered to patients with lung cancer that meet the medical criteria, at the Molecular Medicine Clinic of the Aristotle University of Thessaloniki, based at Papageorgiou Hospital and participates in the World Clinical Study.

What are the criteria for integration into the study

Symphony with Professor of Pathology oncology at the Athens Medical School, Director of the 3rd Pathology Clinic of the Nursing School of Nursing, in “Sotiria”, Constantine Syrigos The vaccine concerns patients with non -microcellular lung cancer.

“There should be quite a large histological piece, (ie biopsy) so that we can work and process it.

The patient should not receive any other intravenous treatment before the patient to join the study. And it should also have no brain metastases. Or if it has brain metastases, they should first be cured. Compared to surgery at the moment the vaccine is evaluated in advanced stages, that is, in stages that already exist metastases, so in patients who do not have an indication for surgery.

If a patient in the past has had a surgery, then a recurrence of his cancer has been presented and made metastases, yes this sick person can get into the study, “the professor said.

According to the clinic manager, oncologist, Molecular Medicine Associate Professor Sofia Baka, “The vaccine is administered to patients who have received chemotherapy and immunotherapy and subsequently operated on lung cancer. Patients will then receive immunotherapy along with the personalized vaccine. ” The vaccine trains and triggers the immune system in order to move against this particular form of cancer.

“Personalized treatment is currently available only for patients taking part in this clinical study. For more information, patients could contact Molecular Medicine Clinic, “Mrs Baka said.